GlassScriptPhysician profile
Miao C Yu
NPI 1255466413
$737.66
in general payments reported to CMS, 2019-2025
14 companies · $92.83 in 2025
The $92.83 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $30.20 · 2022: $12.20 · 2023: $422 · 2025: $92.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $357 · Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $356.81 |
| Food and Beverage | $157.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $356.81 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $88.41 | 2019-2025 | Lo Loestrin Fe, Botox |
| Coopersurgical, INC. | $54.50 | 2019-2025 | Sos |
| Allergan, INC. | $37.83 | 2019 | |
| Smith+Nephew, INC. | $30.40 | 2025 | Pico 7 |
| Hologic Sales and Service, LLC | $27.45 | 2019 | |
| Daiichi Sankyo INC. | $26.98 | 2019 | |
| Meditrina | $21.27 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.70 | 2019 | |
| Astellas Pharma US INC | $15.81 | 2019 | |
| Merck Sharp & Dohme LLC | $15.75 | 2023 | Belsomra, Steglatro |
| Glaxosmithkline, LLC. | $15.73 | 2020 | |
| Avion Pharmaceuticals | $14.55 | 2019 | |
| Aspira Women'S Health INC | $14.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miao Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.